---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-020335"
form_type: "8-K"
ticker: "TGTX"
cik: "0001001316"
company_name: "TG THERAPEUTICS, INC."
filed_at: "2025-06-13T23:59:59+00:00"
generated_at: "2026-05-19T07:27:32.237722+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# TG Therapeutics annual meeting: all proposals pass; say-on-pay gets 54.5% support, director Lonial 54.1%

## Summary
- Six directors elected; Sagar Lonial, MD had lowest support (54.12% for, 40.5M withheld).
- KPMG ratified as independent auditor for FY2025 with 117.8M for (99.6% approval).
- Advisory vote on named executive officer compensation passed with 47.9M for (54.5% of votes cast).
- 2022 Incentive Plan amended to increase authorized shares from 17M to 22M (82.0M for vs 5.8M against).
- Quorum of 118.4M shares (74.58%) represented at meeting.

## SEC filing metadata
- accession: 0001437749-25-020335
- form_type: 8-K
- ticker: TGTX
- cik: 0001001316
- company_name: TG THERAPEUTICS, INC.
- filed_at: 2025-06-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1001316/000143774925020335/0001437749-25-020335-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1001316/000143774925020335/tgtx20250613_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-020335
- JSON: https://secwatch.observer/filing/0001437749-25-020335.json
- Plain text: https://secwatch.observer/filing/0001437749-25-020335.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.